Debt-to-equity in % of Adicet Bio, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adicet Bio, Inc. quarterly Debt-to-equity history and change rate from Q3 2018 to Q3 2025.
  • Adicet Bio, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 21.1 %, a 32.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 21.1 +5.12 +32.1% 30 Sep 2025
Q2 2025 18.4 +1.66 +9.92% 30 Jun 2025
Q1 2025 16.6 -0.66 -3.83% 31 Mar 2025
Q4 2024 15.3 -2.33 -13.2% 31 Dec 2024
Q3 2024 15.9 +0.39 +2.51% 30 Sep 2024
Q2 2024 16.7 +3.08 +22.6% 30 Jun 2024
Q1 2024 17.2 +4.36 +33.9% 31 Mar 2024
Q4 2023 17.6 +5.98 +51.5% 31 Dec 2023
Q3 2023 15.6 +4.24 +37.5% 30 Sep 2023
Q2 2023 13.7 +1.05 +8.33% 30 Jun 2023
Q1 2023 12.9 -0.88 -6.41% 31 Mar 2023
Q4 2022 11.6 -4.84 -29.4% 31 Dec 2022
Q3 2022 11.3 -10.2 -47.4% 30 Sep 2022
Q2 2022 12.6 -11.1 -46.8% 30 Jun 2022
Q1 2022 13.7 -18.8 -57.7% 31 Mar 2022
Q4 2021 16.5 -76.7 -82.3% 31 Dec 2021
Q3 2021 21.5 +105 30 Sep 2021
Q2 2021 23.7 +42.1 30 Jun 2021
Q1 2021 32.5 +56.4 31 Mar 2021
Q4 2020 93.2 +122 31 Dec 2020
Q3 2020 -84 -64.4 -329% 30 Sep 2020
Q2 2020 -18.4 +2.25K +99.2% 30 Jun 2020
Q1 2020 -23.9 -43.3 -224% 31 Mar 2020
Q4 2019 -28.4 -38.4 -384% 31 Dec 2019
Q3 2019 -19.6 -29.3 -302% 30 Sep 2019
Q2 2019 -2.27K 30 Jun 2019
Q1 2019 19.3 31 Mar 2019
Q4 2018 9.99 31 Dec 2018
Q3 2018 9.72 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.